NTLA
Intellia Therapeutics Inc
Biotechnology company focused on CRISPR gene editing
CUSIP: 45826J105HealthcareUS1 holder
Total Value
$105.71M
Total Shares
1.89M
Net Share Change
-339.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$105.71M1.89M shares
TRIM-339.3K(-15.2%)